P

Inventor

BERLIN MICHAEL

US28 patents
⚠️ This page may combine multiple inventors who share the name “BERLIN MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARVINAS OPERATIONS INC

19 patents
US11981683B2May 14, 2024

Indazole based compounds and associated methods of use

ARVINAS OPERATIONS INC5 citations83
US11191741B2Dec 7, 2021

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

ARVINAS OPERATIONS INC3 citations73
US11707452B2Jul 25, 2023

Modulators of alpha-synuclein proteolysis and associated methods of use

ARVINAS OPERATIONS INC2 citations72
US11427548B2Aug 30, 2022

Compounds and methods for the targeted degradation of androgen receptor

ARVINAS OPERATIONS INC2 citations72
US11858940B2Jan 2, 2024

Selective modulators of mutant LRRK2 proteolysis and associated methods of use

ARVINAS OPERATIONS INC2 citations71
US11912699B2Feb 27, 2024

Tau-protein targeting compounds and associated

ARVINAS OPERATIONS INC2 citations69
US12171831B2Dec 24, 2024

Compounds and methods for the targeted degradation of bromodomain- containing proteins

ARVINAS OPERATIONS INC0 citations62
US11857519B2Jan 2, 2024

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

ARVINAS OPERATIONS INC0 citations62
US11554171B2Jan 17, 2023

Compounds and methods for the targeted degradation of bromodomain-containing proteins

ARVINAS OPERATIONS INC0 citations62
US12594264B2Apr 7, 2026

Modulators of alpha-synuclein proteolysis and associated methods of use

ARVINAS OPERATIONS INC0 citations61
US12264157B2Apr 1, 2025

Compounds and methods for the enhanced degradation of targeted proteins

ARVINAS OPERATIONS INC0 citations61
US11512083B2Nov 29, 2022

Compounds and methods for the enhanced degradation of targeted proteins

ARVINAS OPERATIONS INC1 citations61
US12589156B2Mar 31, 2026

Benzimidazole and benzimidazolone based protac compounds for the targeted degradation of leucine rich repeat kinase 2 (LRRK2)

ARVINAS OPERATIONS INC0 citations60
US12559506B2Feb 24, 2026

Indazole based compounds and associated methods of use

ARVINAS OPERATIONS INC0 citations60
US12473294B2Nov 18, 2025

Selective modulators of mutant LRRK2 proteolysis and associated methods of use

ARVINAS OPERATIONS INC0 citations60
US12559486B2Feb 24, 2026

Tau-protein targeting compounds and associated methods of use

ARVINAS OPERATIONS INC0 citations58
US12441708B2Oct 14, 2025

Cereblon ligands and bifunctional compounds comprising the same

ARVINAS OPERATIONS INC0 citations52
US12539292B2Feb 3, 2026

BRM targeting compounds and associated methods of use

ARVINAS OPERATIONS INC0 citations51
US12310975B2May 27, 2025

Modulators of BCL6 proteolysis and associated methods of use

ARVINAS OPERATIONS INC0 citations51

MERCK SHARP & DOHME

5 patents

ARVINAS INC

3 patents

BERLIN MICHAEL

1 patent